KYVERNA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.005 USD | -8.79% |
|
-6.60% | 0.00% |
| Jul. 03 | HC Wainwright Initiates Kyverna Therapeutics at Neutral With $8 Price Target | MT |
| Jul. 01 | Kyverna Therapeutics, Inc.(NasdaqGS:KYTX) added to Russell Small Cap Comp Value Index | CI |
Evolution of the average Target Price on Kyverna Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
3818.oxbflgx6Lq8mj-Ydc0dhcwVnFbPYrqsOZRQgm-9FExM.-ia3o3Y9R5tEurd7IAMpLGAgUfmy9t5LCVl40LgoQEr0d5LQRQB3yXCirw~390b059ceb7520bfcb62d03e0e0e4030
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
7.005
USD
Average target price
35.8
USD
Spread / Average Target
+411.06%
High Price Target
48
USD
Spread / Highest target
+585.22%
Low Price Target
8
USD
Spread / Lowest Target
+14.20%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Kyverna Therapeutics, Inc.
| Morgan Stanley | |
| JPMorgan Chase |
EPS Revisions
- Stock Market
- Equities
- KYTX Stock
- Consensus Kyverna Therapeutics, Inc.
